Apogem Capital’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-37,784
| Closed | -$548K | – | 58 |
|
|
2022
Q3 | $548K | Sell |
37,784
-24,103
| -39% | -$350K | 0.55% | 58 |
|
|
2022
Q2 | $609K | Buy |
61,887
+18,157
| +42% | +$179K | 0.55% | 58 |
|
|
2022
Q1 | $645K | Buy |
43,730
+12,967
| +42% | +$191K | 0.44% | 78 |
|
|
2021
Q4 | $407K | Buy |
30,763
+10,697
| +53% | +$142K | 0.27% | 112 |
|
|
2021
Q3 | $350K | Buy |
20,066
+6,306
| +46% | +$110K | 0.22% | 134 |
|
|
2021
Q2 | $330K | Buy |
+13,760
| New | +$330K | 0.21% | 135 |
|